Akademisyen
ÖZGE GÜNGÖR
DOKTOR ÖĞRETİM ÜYESİ
KAHRAMANMARAŞ SÜTÇÜ İMAM ÜNİVERSİTESİ FEN FAKÜLTESİ KİMYA BÖLÜMÜ
- Ana Dal Fen Bilimleri ve Matematik Temel Alanı
- Yan Dal Kimya
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 70
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
9
Q2
47
Q3
8
Q4
2
WoS (JCR)
Q1
14
Q2
24
Q3
27
Q4
1
TR Index
2
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
15
Ort. yüzdelik
74.2%
Üst %1 payı
0.0%
Üst %10 payı
22.1%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 1,2,3‐Triazole Isonicotinate/Nicotinate Derivatives as Cholinesterase and α‐Amylase Inhibitors: Synthesis, Enzyme Inhibition, Antioxidant Activity, and Molecular Docking Studies YÖKSİS SJR Q2 JCR Q3 OpenAlex 89.4%
- 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groups YÖKSİS SJR Q2 JCR Q2 OpenAlex 80.9%
- 2026 Synthesis, BuChE and AChE Enzyme Inhibition and Molecular Docking Studies of Hydrazide-Hydrazone Schiff Base Compound Containing Propargyl/Pyridine Moiety YÖKSİS TR Index OpenAlex 16.9%
- 2025 The triphenylphosphonium appended Schiff base ligands and their half-sandwich Ru(II) complexes: DNA binding, Anticancer and antioxidant properties YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.9%
- 2025 New 1,2,3-triazoles and their oxime derivatives: AChE/BChE enzyme inhibitory and DNA binding properties YÖKSİS SJR Q2 JCR Q3 OpenAlex 85.0%
- 2025 New azo-azomethine based Cu(II) and Zn(II) complexes: Synthesis, DNA binding, antioxidant activity and molecular docking studies YÖKSİS SJR Q2 JCR Q2 OpenAlex 84.8%
- 2025 Low toxicity ferrocene-1,2,3-Triazole hybrids as acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, antioxidant activity, enzyme inhibition, cytotoxicity properties and molecular docking studies YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.5%
- 2025 New 1,2,3-triazole-quinazolinone skeleton as potential cholinesterase and α-amylase inhibitors: In vitro and in silico studies YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.9%
- 2025 Keggin POM-based hybrids decorated with aminopyridines. Determination of their molecular structure, electrochemical behaviors, antimicrobial and anticancer activities YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 94.0%
- 2025 1,2,3-Triazole naphthaldehyde compounds and their oxime derivatives: in vitro and in silico DNA binding properties YÖKSİS SJR Q2 JCR Q3 OpenAlex 89.9%
- 2025 Pyrimidine-biguanide Compounds: Choline Esterase Inhibitory Properties and In Silico Studies YÖKSİS SJR Q2 JCR Q2 OpenAlex 70.5%
- 2025 Copper(II) and Zinc(II) complexes of new water-soluble Schiff base ligands and their antiproliferative properties towards mesothelioma cell line YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 93.3%
- 2024 Homoleptic metal complexes derived from hydrazones as ligand; synthesis, cytotoxic activity, photoluminescence properties and ADMET studies YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 93.9%
- 2024 New sulfonamide derivatives based on 1,2,3-triazoles: synthesis, in vitro biological activities and in silico studies YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 92.1%
- 2024 New Cu (II) and Zn (II) metal chelates derived from azo‐Schiff bases: Synthesis, DNA/BSA binding, anticancer activity and molecular docking studies YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.5%
- 2024 DNA/BSA Binding and Antimicrobial Properties of Biguanide‐Cu(II) Complexes YÖKSİS SJR Q3 JCR Q3 OpenAlex 60.6%
- 2024 New metal-based drugs: spectral, electrochemical, DNA-binding and anticancer activity properties YÖKSİS SJR Q3 JCR Q3 OpenAlex 23.7%
- 2024 A Series of Biguanide Ligands and Their Cu(II) Complexes: Cholinesterase Inhibitory and Antimicrobial Properties YÖKSİS SJR Q3 JCR Q3 OpenAlex 72.0%
- 2024 Synthesis, DNA binding and anticancer properties of new Cu(II) and Zn(II) complexes of a Schiff base ligand containing a triphenylphosphonium as a lipophilic cation YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 90.3%
- 2023 A Novel Donepezil–Caffeic Acid Hybrid: Synthesis, Biological Evaluation, and Molecular Docking Studies YÖKSİS SJR Q2 JCR Q3 OpenAlex 59.9%